1.Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy.
Seul LEE ; Dong Hyun KIM ; Sung Yong OH ; So Yeon KIM ; Myeong Seok KOH ; Ji Hyun LEE ; Suee LEE ; Sung Hyun KIM ; Jong Young KWAK ; Min Gyoung PAK ; Mi Ha JU ; Hyo Jin KIM ; Jin Sook JEONG
The Korean Journal of Internal Medicine 2017;32(2):335-344
BACKGROUND/AIMS: CD11c is a dendritic cell marker in humans, which potentially induces a cytotoxic effect on lymphoma cells. Forkhead boxP3 (FOXP3) is a regulator of T lymphocyte in the microenvironment of the lymphoma. The principal objective of this study was to determine whether the tumors' microenvironment expressions of CD11c and FOXP3 are predictive of clinical outcomes in diffuse large B-cell lymphoma (DLBCL) patients receiving treatment with rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy. METHODS: The study population consisted of 100 patients with DLBCL. The CD11c and FOXP3 expression in primary tumors' microenvironment were evaluated using an immunohistochemistry (IHC). RESULTS: CD11c and FOXP3 expression positivity in microenvironment were 25% and 35%, respectively. Each one counted for 1 point. In CD11c and FOXP3 stain, positive was counted as 0 and negative was 1. The points were separated into low risk (0 to 1) and high risk (2) groups. Only the extranodal DLBCL patient group analysis conveyed significant differences of progression-free survival (p = 0.019) and overall survival (p = 0.039) between the two groups. CONCLUSIONS: We can achieve possible clinical significance of lymphoma tumor microenvironments through CD11c and FOXP3 IHC stains in extranodal DLBCL patients receiving R-CHOP therapy.
B-Lymphocytes*
;
Coloring Agents
;
Cyclophosphamide*
;
Dendritic Cells
;
Disease-Free Survival
;
Drug Therapy, Combination*
;
Humans
;
Immunohistochemistry
;
Lymphocytes
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, Large B-Cell, Diffuse
;
Prednisone*
;
Rituximab*
;
Tumor Microenvironment*
;
Vincristine*
2.The Effect of Transcranial Direct Current Stimulation on Neglect Syndrome in Stroke Patients.
You Gyoung YI ; Min Ho CHUN ; Kyung Hee DO ; Eun Jung SUNG ; Yong Gyu KWON ; Dae Yul KIM
Annals of Rehabilitation Medicine 2016;40(2):223-229
OBJECTIVE: To examine whether transcranial direct current stimulation (tDCS) applied over the posterior parietal cortex (PPC) improves visuospatial attention in stroke patients with left visuospatial neglect. METHODS: Patients were randomly assigned to 1 of 3 treatment groups: anodal tDCS over the right PPC, cathodal tDCS over the left PPC, or sham tDCS. Each patient underwent 15 sessions of tDCS (5 sessions per week for 3 weeks; 2 mA for 30 minutes in each session). Outcome measures were assessed before treatment and 1 week after completing the treatment. RESULTS: From pre- to post-treatment, there was an improvement in the motor-free visual perception test (MVPT), line bisection test (LBT), star cancellation test (SCT), Catherine Bergego Scale (CBS), Korean version of Modified Barthel Index (K-MBI), and Functional Ambulation Classification in all 3 groups. Improvements in the MVPT, SCT, and LBT were greater in the anodal and cathodal groups than in the sham group. However, improvements in other outcomes were not significantly different between the 3 groups, although there was a tendency for improved CBS or K-MBI scores in the anodal and cathodal groups, as compared with the sham group. CONCLUSION: The study results indicated that the facilitatory effect of anodal tDCS applied over the right PPC, and the inhibitory effect of cathodal tDCS applied over the left PPC, improved symptoms of visuospatial neglect. Thus, tDCS could be a successful adjuvant therapeutic modality to recover neglect symptom, but this recovery might not lead to improvements in activities of daily living function and gait function.
Activities of Daily Living
;
Classification
;
Gait
;
Humans
;
Outcome Assessment (Health Care)
;
Rabeprazole
;
Stroke*
;
Visual Perception
;
Walking
3.The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Soyeon LEE ; Hyo Gyoung KANG ; Jin Eun CHOI ; Jang Hyuck LEE ; Hyo Jung KANG ; Sun Ah BAEK ; Eungbae LEE ; Yangki SEOK ; Won Kee LEE ; Shin Yup LEE ; Seung Soo YOO ; Jaehee LEE ; Seung Ick CHA ; Chang Ho KIM ; Sukki CHO ; Jae Yong PARK
Journal of Korean Medical Science 2016;31(11):1735-1741
Vascular endothelial growth factor (VEGF) contributes to tumor angiogenesis. The role of VEGF single nucleotide polymorphisms (SNPs) in lung cancer susceptibility and its prognosis remains inconclusive and controversial. This study was performed to investigate whether VEGF polymorphisms affect survival outcomes of patients with early stage non-small cell lung cancer (NSCLC) after surgery. Three potentially functional VEGF SNPs (rs833061T>C, rs2010963G>C, and rs3025039C>T) were genotyped. A total of 782 NSCLC patients who were treated with surgical resection were enrolled. The association of the SNPs with overall survival (OS) and disease free survival (DFS) was analyzed. In overall population, none of the three polymorphisms were significantly associated with OS or DFS. However, when the patients were stratified by tumor histology, squamous cell carcinoma (SCC) and adenocarcinoma (AC) had significantly different OS (Adjusted hazard ratio [aHR] = 0.76, 95% CI = 0.56–1.03 in SCC; aHR = 1.33, 95% CI = 0.98–1.82 in AC; P for heterogeneity = 0.01) and DFS (aHR = 0.75, 95% CI = 0.58–0.97 in SCC; aHR = 1.26, 95% CI = 1.00–1.60 in AC; P for heterogeneity = 0.004) according to the rs833061T>C genotypes. Our results suggest that the prognostic role of VEGF rs833061T>C may differ depending on tumor histology.
Adenocarcinoma
;
Carcinoma, Non-Small-Cell Lung*
;
Carcinoma, Squamous Cell
;
Disease-Free Survival
;
Genotype
;
Humans
;
Lung Neoplasms
;
Polymorphism, Single Nucleotide
;
Population Characteristics
;
Prognosis*
;
Vascular Endothelial Growth Factor A*
4.Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study.
Sung Il PARK ; Il Jung KIM ; Shin Jae LEE ; Min Woo SHIN ; Wonseon SHIN ; Yong Eun CHUNG ; Gyoung Min KIM ; Man Deuk KIM ; Jong Yun WON ; Do Yun LEE ; Jin Sub CHOI ; Kwang Hyub HAN
Korean Journal of Radiology 2016;17(5):742-749
OBJECTIVE: To evaluate the feasibility of angled cool-tip electrode for radiofrequency ablation of small superficial subcapsular liver tumors abutting abdominal wall, in order to traverse normal liver parenchyma, and thereby, obtain favorable configuration of ablation margin. MATERIALS AND METHODS: In this study, we retrospectively analyzed 15 small superficial subcapsular liver tumors abutting abdominal wall in 15 patients, treated with radiofrequency ablation from March 2013 to June 2015 using a cool-tip electrode manually modified to create 25-35° angle at the junction between exposed and insulated segments. The tumors were hepatocellular carcinoma (n = 13) and metastases (n = 2: cholangiocellular carcinoma and rectosigmoid cancer), with maximum diameter of 10-26 mm (mean, 15.68 ± 5.29 mm). Under ultrasonographic guidance, the electrode tip was advanced to the depth of the tumors' epicenter about 1 cm from the margin. The tip was re-directed to penetrate the tumor for radiofrequency ablation. Minimal ablation margin was measured at immediate post-treatment CT. Radiological images and medical records were evaluated for success rate, length of minimal ablation margin and complications. RESULTS: Technical success rate of obtaining complete necrosis of the tumors was 100%, with no procedure-related complication. Minimal ablation margin ranged from 3-12 mm (mean, 7.07 ± 2.23 mm). CT/MRI follow-up at 21-1022 days (mean, 519.47 ± 304.51 days) revealed no local recurrence, but distant recurrence in 9 patients. CONCLUSION: Using an angled cool-tip electrode for radiofrequency ablation of small superficial subcapsular tumors abutting abdominal wall may be a feasible technique for obtaining adequate ablation margin and lower complication rate.
Abdominal Wall
;
Carcinoma, Hepatocellular
;
Catheter Ablation*
;
Cholangiocarcinoma
;
Electrodes*
;
Feasibility Studies*
;
Follow-Up Studies
;
Humans
;
Liver*
;
Medical Records
;
Necrosis
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
5.Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis.
In Jin CHO ; Ho Yeon CHUNG ; Sung Woon KIM ; Jae Won LEE ; Tae Won LEE ; Hye Soon KIM ; Sin Gon KIM ; Han Seok CHOI ; Sung Hee CHOI ; Chan Soo SHIN ; Ki Won OH ; Yong Ki MIN ; Jung Min KOH ; Yumie RHEE ; Dong Won BYUN ; Yoon Sok CHUNG ; Jeong Hyun PARK ; Dong Jin CHUNG ; Minho SHONG ; Eun Gyoung HONG ; Chang Beom LEE ; Ki Hyun BAEK ; Moo Il KANG
Endocrinology and Metabolism 2015;30(3):272-279
BACKGROUND: The present study evaluated the efficacy of a combination of ibandronate and cholecalciferol on the restoration of the levels of 25-hydroxyvitamin D (25[OH]D) and various bone markers in postmenopausal women with osteoporosis. METHODS: This was a randomized, double-blind, active-controlled, prospective 16-week clinical trial conducted in 20 different hospitals. A total of 201 postmenopausal women with osteoporosis were assigned randomly to one of two groups: the IBN group, which received a once-monthly pill containing 150 mg ibandronate (n=99), or the IBN+ group, which received a once-monthly pill containing 150 mg ibandronate and 24,000 IU cholecalciferol (n=102). Serum levels of 25(OH)D, parathyroid hormone (PTH), and various bone markers were assessed at baseline and at the end of a 16-week treatment period. RESULTS: After 16 weeks of treatment, the mean serum levels of 25(OH)D significantly increased from 21.0 to 25.3 ng/mL in the IBN+ group but significantly decreased from 20.6 to 17.4 ng/mL in the IBN group. Additionally, both groups exhibited significant increases in mean serum levels of PTH but significant decreases in serum levels of bone-specific alkaline phosphatase and C-telopeptide of type 1 collagen (CTX) at 16 weeks; no significant differences were observed between the groups. However, in subjects with a vitamin D deficiency, IBN+ treatment resulted in a significant decrease in serum CTX levels compared with IBN treatment. CONCLUSION: The present findings demonstrate that a once-monthly pill containing ibandronate and cholecalciferol may be useful for the amelioration of vitamin D deficiency in patients with postmenopausal osteoporosis. Moreover, this treatment combination effectively decreased serum levels of resorption markers, especially in subjects with a vitamin D deficiency, over the 16-week treatment period.
Alkaline Phosphatase
;
Cholecalciferol*
;
Collagen Type I
;
Female
;
Humans
;
Osteoporosis*
;
Osteoporosis, Postmenopausal
;
Parathyroid Hormone
;
Prospective Studies
;
Vitamin D Deficiency
6.Chronic renal failure induces cell death in rat hippocampal CA1 via upregulation of alphaCaMKII/NR2A synaptic complex and phosphorylated GluR1-containing AMPA receptor cascades.
Jong Wan KIM ; Gyoung Yim HA ; Yong Wook JUNG
Kidney Research and Clinical Practice 2014;33(3):132-138
BACKGROUND: N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propinoic acid (AMPA) receptors bound to postsynaptic density-95 (PSD-95) and alpha isoform of calcium/calmodulin-dependent protein kinase II (alphaCaMKII) is fundamentally involved in the regulation of working memory. The aim of present study was to investigate the alterations of NMDA and AMPA receptors responsible for hippocampal synaptic dysfunction and selective neuronal cell death after chronic renal failure (CRF) which may be associated with impairment of working memory. METHODS: Altered interactions between NMDA and AMPA receptors and PSD-95 and alphaCaMKII were analyzed in the cornu ammonis (CA) 1 and CA3/dentate gyrus (DG) subfields of the uremic rat hippocampi using the immunoblotting and immunoprecipitation methods. RESULTS: Uremia induced by CRF produced necrotic cell death and decreased neuronal nucleoli protein levels in the hippocampal CA1 subfield, but not in the CA3/DG subfields. The CA1 subfields of CRF rats exhibited significant decreases and increases, respectively, in the expressions of PSD-95/NR2B and alphaCaMKII/NR2A synaptic complex. Moreover, increased phosphorylation of glutamate receptor type 1 (GluR1) AMPA receptor at ser831 was observed in the CA1 subfield after CRF. CONCLUSION: These hippocampal CA1 neuronal vulnerability may be responsible for memory dysfunction after CRF as mediated by an increase in NR2A-containing NMDA receptors bound to alphaCaMKII and subsequent activation of GluR1-containing AMPA receptors caused by the phosphorylation of GluR1 at ser831.
Animals
;
Cell Death*
;
Hippocampus
;
Immunoblotting
;
Immunoprecipitation
;
Kidney Failure, Chronic*
;
Memory
;
Memory, Short-Term
;
N-Methylaspartate
;
Neurons
;
Phosphorylation
;
Protein Kinases
;
Rats*
;
Receptors, AMPA*
;
Receptors, Glutamate
;
Receptors, N-Methyl-D-Aspartate
;
Up-Regulation*
;
Uremia
7.Current status of assisted reproductive technology in Korea, 2009.
Young Min CHOI ; Sang Sik CHUN ; Hyuck Dong HAN ; Jung Hye HWANG ; Kyung Joo HWANG ; In Soo KANG ; Dong Won KIM ; Ki Chul KIM ; Tak KIM ; Hyuck Chan KWON ; Won Don LEE ; Jung Ho LEE ; Kyu Sup LEE ; Gyoung Hoon LEE ; Sang Hoon LEE ; Yu Il LEE ; Eung Gi MIN ; Hwa Sook MOON ; Shin Yong MOON ; Sung Il ROH ; Tae Ki YOON
Obstetrics & Gynecology Science 2013;56(6):353-361
Great advances have been made in the field of assisted reproductive technology (ART) since the first in vitro fertilization (IVF) baby was born in Korea in the year of 1985. However, it deserve to say that the invaluable data from fertility centers may serve as a useful source to find out which factors affect successful IVF outcome and to offer applicable information to infertile patients and fertility clinics. This article intended to report the status of ART in 2009 Korean Society of Obstetrics and Gynecology surveyed. The current survey was performed to assess the status and success rate of ART performed in Korea, between January 1 and December 31, 2009. Reporting forms had been sent out to IVF centers via e-mail, and collected by e-mail as well in 2012. With International Committee Monitoring Assisted Reproductive Technologies recommendation, intracytoplasmic sperm injection (ICSI) and non-ICSI cases have been categorized and also IVF-ET cases involving frozen embryo replacement have been surveyed separately. Seventy-four centers have reported the treatment cycles initiated in the year of 2009, and had performed a total of 27,947 cycles of ART treatments. Among a total of 27,947 treatment cycles, IVF and ICSI cases added up to 22,049 (78.9%), with 45.3% IVF without ICSI and 54.7% IVF with ICSI, respectively. Among the IVF and ICSI patients, patients confirmed to have achieved clinical pregnancy was 28.8% per cycle with oocyte retrieval, and 30.9% per cycle with embryo transfer. The most common number of embryos transferred in 2009 is three embryos (40.4%), followed by 2 embryos (28.4%) and a single embryo transferred (13.6%). Among IVF and ICSI cycles that resulted in multiple live births, twin pregnancy rate was 45.3% and triple pregnancy rate was 1.1%. A total of 191 cases of oocyte donation had been performed to result in 25.0% of live birth rate. Meanwhile, a total of 5,619 cases of frozen embryo replacement had been performed with 33.7% of clinical pregnancy rate per cycle with embryo transfer. When comparing with international registry data, clinical pregnancy rate per transfer from fresh IVF cycles including ICSI (34.1%,) was comparable to clinical pregnancy rate per transfer in European Society for Human Reproduction and Embryology report was 32.5% though lower than 45.0% for USA data. There was no remarkable difference in status of assisted reproductive technology in Korea between the current report and the data reported in 2008. The age of women trying to get pregnant was reconfirmed to be the most important factor that may have impact on success of ART treatment.
Electronic Mail
;
Embryo Transfer
;
Female
;
Fertility
;
Fertilization in Vitro
;
Humans
;
Korea*
;
Live Birth
;
Oocyte Donation
;
Oocyte Retrieval
;
Pregnancy
;
Pregnancy Rate
;
Pregnancy, Twin
;
Reproduction
;
Reproductive Techniques
;
Reproductive Techniques, Assisted*
;
Sperm Injections, Intracytoplasmic
8.EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer.
Guang JIN ; Hyo Sung JEON ; Eung Bae LEE ; Hyo Gyoung KANG ; Seung Soo YOO ; Shin Yup LEE ; Jae Hee LEE ; Sung Ick CHA ; Tae In PARK ; Chang Ho KIM ; Sang Hoon JHEON ; Jae Yong PARK
Journal of Korean Medical Science 2012;27(2):228-230
A fusion gene between echinoderm microtubule-associated protein-like 4 (EML4) and the anaplastic lymphoma kinase (ALK) has been identified in non-small cell lung cancers (NSCLCs). Although a few studies have evaluated EML4-ALK fusion genes in Korean NSCLCs, the prevalence of different EML4-ALK fusion variants has yet to be clearly assessed. Herein, we have examined the profiles of EML4-ALK fusion gene variants in Korean patients of NSCLCs. EML4-ALK fusion genes have been detected in 10 (6.0%) of 167 patients of NSCLCs and in 9 (7.4%) of 121 patients of adenocarcinoma. Of the 10 patients with fusion genes identified, 8 (80%) were E13;A20 (variant 1) and 2 (20%) were E6;A20, with an additional 33-bp sequence derived from intron 6 of EML4 (variant 3b). These results indicate that the profiles of EML4-ALK fusion gene variants in Korean patients of NSCLC may differ from those in other ethnic populations. Herein, we describe for the first time the profiles of EML4-ALK fusion variants of Korean patients with NSCLCs.
Adenocarcinoma/diagnosis/genetics
;
Aged
;
Asian Continental Ancestry Group/*genetics
;
Base Sequence
;
Carcinoma, Non-Small-Cell Lung/diagnosis/*genetics
;
Exons
;
Female
;
Humans
;
Introns
;
Lung Neoplasms/diagnosis/*genetics
;
Male
;
Middle Aged
;
Oncogene Proteins, Fusion/chemistry/*genetics
;
Republic of Korea
;
Sequence Analysis, RNA
;
Smoking
9.A Functional Polymorphism in the CHRNA3 Gene and Risk of Chronic Obstructive Pulmonary Disease in a Korean Population.
Jae Yeon LEE ; Seung Soo YOO ; Hyo Gyoung KANG ; Guang JIN ; Eun Young BAE ; Yi Young CHOI ; Jin Eun CHOI ; Hyo Sung JEON ; Jaehee LEE ; Shin Yup LEE ; Seung Ick CHA ; Chang Ho KIM ; Jae Yong PARK
Journal of Korean Medical Science 2012;27(12):1536-1540
A genome-wide association study has identified the 15q25 region as being associated with the risk of chronic obstructive pulmonary disease (COPD) in Caucasians. This study intended as a confirmatory assessment of this association in a Korean population. The rs6495309C > T polymorphism in the promoter of nicotinic acetylcholine receptor alpha subunit 3 (CHRNA3) gene was investigated in a case-control study that consisted of 406 patients with COPD and 394 healthy control subjects. The rs6495309 CT or TT genotype was associated with a significantly decreased risk of COPD when compared to the rs6495309 CC genotype (adjusted odds ratio = 0.69, 95% confidence interval = 0.50-0.95, P = 0.023). The effect of the rs6495309C > T on the risk of COPD was more evident in moderate to very severe COPD than in mild COPD under a dominant model for the variant T allele (P = 0.024 for homogeneity). The CHRNA3 rs6495309C > T polymorphism on chromosome 15q25 is associated with the risk of COPD in a Korean population.
Adult
;
Aged
;
Alleles
;
Asian Continental Ancestry Group/*genetics
;
Case-Control Studies
;
Female
;
Forced Expiratory Volume
;
Genotype
;
Humans
;
Male
;
Middle Aged
;
Odds Ratio
;
*Polymorphism, Single Nucleotide
;
Pulmonary Disease, Chronic Obstructive/*genetics/physiopathology
;
Receptors, Nicotinic/*genetics
;
Republic of Korea
;
Risk Factors
;
Smoking
10.Asan Medical Information System for Healthcare Quality Improvement.
Hyeon Jeong RYU ; Woo Sung KIM ; Jae Ho LEE ; Sung Woo MIN ; Sun Ja KIM ; Yong Su LEE ; Young Ha LEE ; Sang Woo NAM ; Gi Seung EO ; Sook Gyoung SEO ; Mi Hyun NAM
Healthcare Informatics Research 2010;16(3):191-197
OBJECTIVES: This purpose of this paper is to introduce the status of the Asan Medical Center (AMC) medical information system with respect to healthcare quality improvement. METHODS: Asan Medical Information System (AMIS) is projected to become a completely electronic and digital information hospital. AMIS has played a role in improving the health care quality based on the following measures: safety, effectiveness, patient-centeredness, timeliness, efficiency, privacy, and security. RESULTS: AMIS consisted of several distinctive systems: order communication system, electronic medical record, picture archiving communication system, clinical research information system, data warehouse, enterprise resource planning, IT service management system, and disaster recovery system. The most distinctive features of AMIS were the high alert-medication recognition & management system, the integrated and severity stratified alert system, the integrated patient monitoring system, the perioperative diabetic care monitoring and support system, and the clinical indicator management system. CONCLUSIONS: AMIS provides IT services for AMC, 7 affiliated hospitals and over 5,000 partners clinics, and was developed to improve healthcare services. The current challenge of AMIS is standard and interoperability. A global health IT strategy is needed to get through the current challenges and to provide new services as needed.
Decision Support Systems, Clinical
;
Delivery of Health Care
;
Disasters
;
Electronic Health Records
;
Electronics
;
Electrons
;
Hospital Information Systems
;
Information Systems
;
Monitoring, Physiologic
;
Privacy
;
Quality of Health Care

Result Analysis
Print
Save
E-mail